Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity
Viralkumar Davra et al.
CANCER RESEARCH (2021)
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
Sara A. Vayrynen et al.
CLINICAL CANCER RESEARCH (2021)
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming
Sen Yang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Erythroblastic Island Macrophages Shape Normal Erythropoiesis and Drive Associated Disorders in Erythroid Hematopoietic Diseases
Wei Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer
Wenting Du et al.
MOLECULAR CANCER RESEARCH (2021)
Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker
Andrew X. Chen et al.
GENOME MEDICINE (2021)
Trends in clinical development for PD-1/PD-L1 inhibitors
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
Dongbo Li et al.
CANCER SCIENCE (2020)
Tumor-Associated Macrophages: Recent Insights and Therapies
Jiawei Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
Wanzun Lin et al.
FRONTIERS IN ONCOLOGY (2020)
Mechanisms of immune escape in the cancer immune cycle
Sha Tang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naive Gastroesophageal Adenocarcinoma
Martin Jeremiasen et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
Tracy C. Kuo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells
Silke Eisinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis
Kulthida Vaeteewoottacharn et al.
TRANSLATIONAL ONCOLOGY (2019)
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
Gregor Sturm et al.
BIOINFORMATICS (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
Seon Ah Lim et al.
FRONTIERS IN IMMUNOLOGY (2019)
Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer
Yu Pan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
Chenjing Zhu et al.
MOLECULAR CANCER (2019)
Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer
Linnea La Fleur et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
Carole Achard et al.
EBIOMEDICINE (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
Amira A. Barkal et al.
NATURE IMMUNOLOGY (2018)
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer
Kathleen F. Ludwig et al.
CANCER RESEARCH (2018)
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer
Alex D. Michaels et al.
CLINICAL CANCER RESEARCH (2018)
Nanomedicine Strategies to Target Tumor-Associated Macrophages
Karin Binnemars-Postma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Association of decreased expression of the macrophage scavenger receptor MARCO with tumor progression and poor prognosis in human hepatocellular carcinoma
Haoyu Sun et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype
Sebastian Lundgren et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
The significance of TIMD4 expression in clear cell renal cell carcinoma
Hiromu Yano et al.
MEDICAL MOLECULAR MORPHOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
Much more than M1 and M2 macrophages, there are also CD169+ and TCR+ macrophages
Leslie Chavez-Galan et al.
FRONTIERS IN IMMUNOLOGY (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Functional relationship between tumor-associated macropnages and macropnage colony-stimulating factor as contributors to cancer progression
Damya Laoui et al.
FRONTIERS IN IMMUNOLOGY (2014)
TIM-4 Glycoprotein-Mediated Degradation of Dying Tumor Cells by Autophagy Leads to Reduced Antigen Presentation and Increased Immune Tolerance
Muhammad Baghdadi et al.
IMMUNITY (2013)
Carcinoembryonic antigen-related cell adhesion molecule 1 negatively regulates granulocyte colony-stimulating factor production by breast tumor-associated macrophages that mediate tumor angiogenesis
Sridhar Samineni et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Macrophage Scavenger Receptor A Promotes Tumor Progression in Murine Models of Ovarian and Pancreatic Cancer
Claudine Neyen et al.
JOURNAL OF IMMUNOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts
Laetitia Fend et al.
PLOS ONE (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
The functional role of cell adhesion molecules in tumor angiogenesis
Chiara Francavilla et al.
SEMINARS IN CANCER BIOLOGY (2009)
Tumor escape mechanism governed by myeloid-derived suppressor cells
Srinivas Nagaraj et al.
CANCER RESEARCH (2008)
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance
Paola Allavena et al.
IMMUNOLOGICAL REVIEWS (2008)
Can cancer be reversed by engineering the tumor microenvironment?
Donald E. Ingber
SEMINARS IN CANCER BIOLOGY (2008)
Immune resistance orchestrated by the tumor microenvironment
Thomas F. Gajewski et al.
IMMUNOLOGICAL REVIEWS (2006)
Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells
H Yoshida et al.
NATURE (2005)
Share Paper
